NY-CIRIUM
23.8.2022 14:02:54 CEST | Business Wire | Press release
Cirium, the aviation analytics firm, has announced that former Spirit Airlines CEO, Ben Baldanza and former Indigo CCO, Willy Boulter have joined the Cirium On-Time Performance (OTP) Advisory Board.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220823005442/en/
Cirium is the first and only company that has an OTP Advisory Board in the aviation industry. The Board comprises a collaborative team of external advisors who support Cirium’s OTP Program and reports global Annual and Monthly airline and airport on-time analyses.
“We are delighted to welcome Ben and Willy to the Cirium OTP Advisory Board. Together they bring nearly 80 years of aviation experience to the Board, which will be invaluable for Cirium’s airline and airport OTP Program. They will provide key focus and direction on the big-picture initiatives,” said Jeremy Bowen , CEO at Cirium.
Ben Baldanza is a transformational leader in the US airline industry. He was president and CEO for Spirit Airlines and changed that airline into an ultra-low-cost-airline carrier. Prior to Spirit he held executive roles with US Airways, Continental Airlines and TACA Airlines.
In addition to the Cirium OTP Board, Baldanza currently serves on the Board of Directors for JetBlue Airways, Six Flags Entertainment and several private companies. He also co-hosts a weekly podcast that is now in the top 1% of all podcasts by weekly listeners. Baldanza has also been twice named as one of the industry’s 25 Most Influential Leaders .
Baldanza said: “Airline and airport operational performance is increasingly important as the industry recovers from the pandemic and contends with rising challenges such as forecasting travel demand. Cirium’s OTP Program measures the carriers’ and airports’ operational efficiencies and is the standard for on-time arrival and departure benchmarking.”
Willy Boulter has 40 years’ experience in the airline industry, most recently as CCO at India’s largest airline IndiGo. Prior to IndiGo, Boulter was CCO in the Emirates-sponsored team that turned around TAAG Angola Airlines. He held executive roles at Gulf Air, Etihad Airways, low-cost carrier Sky Express, Virgin Atlantic and Cathay Pacific. Boulter also served in the British Army in the UK, Canada and Hong Kong and is a fellow of the Royal Aeronautical Society.
Boulter said: “It’s a privilege to join the Cirium OTP Advisory Board to help steer an accurate analysis of airline and airport operations. The program has multiple benefits for the industry, not least enabling improved operational performance and tracking aircraft utilization aligned to sustainability targets.”
Baldanza and Boulter join Luis Felipe de Oliveira , Director General at ACI World and Henry H. Harteveldt, President – Travel Industry Analyst at Atmosphere Research Group on the Board.
Click here to download the latest Cirium On-Time Performance Monthly Report.
Ends
About Cirium
Cirium brings together powerful data and analytics to keep the world moving. Delivering insight, built from decades of experience in the sector, enabling travel companies, aircraft manufacturers, airports, airlines and financial institutions, among others, to make logical and informed decisions which shape the future of travel, growing revenues and enhancing customer experiences. Cirium is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.
For further information please follow Cirium updates on LinkedIn or Twitter or visit www.cirium.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220823005442/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Echodyne Opens New Manufacturing Facility to Meet Surging Global Demand for Advanced MESA® Radar9.7.2026 15:00:00 CEST | Press release
New Washington State facility provides capacity to manufacture more than 30,000 radars annually, strengthening the U.S. defense industrial base As governments around the world accelerate investment in counter-unmanned aircraft systems (C-UAS) and short-range air defense, Echodyne today announced the opening of a new advanced radar manufacturing facility in Washington State, significantly expanding its manufacturing capacity to meet rapidly growing demand from U.S. and allied customers. With millions of drones manufactured and used by both sides in the Russian War in Ukraine, the need for enhanced safety for defense, national security, and critical infrastructure assets grows with every successful strike and interception. The low cost and high utility of drones dramatically alters the need for safety and security sensors. And as the low altitude economy takes off, hundreds of thousands of drones will perform a range of life-saving and commercial missions, requiring a sensor infrastructu
Orca Security Report: 99.9% of Fixable AI Vulnerabilities Remain Unpatched as AI Moves Into Production9.7.2026 15:00:00 CEST | Press release
Analysis of more than 1,200 production cloud environments provides a first-hand view into how organizations are embedding AI into business-critical workflows, exposing new security risks that traditional controls weren't built to address. Orca Security, a leader in cloud and AI security, today released its 2026 State of AI Security Report, offering a first-hand view into how AI is being deployed across more than 1,200 production cloud environments. The findings show AI is no longer limited to isolated pilots or developer experiments. Organizations are embedding AI into production applications, cloud services, and autonomous workflows faster than security programs can adapt. More than half (56%) of organizations have already deployed AI agents into production, while 51% use AI to build custom applications. At the same time, Orca found that 81% of organizations run vulnerable AI packages, and 99.9% of fixable AI vulnerabilities remain unpatched, highlighting how quickly AI has become ope
Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration9.7.2026 15:00:00 CEST | Press release
Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai's health system network Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Cortechs.ai, a global leader in neuroimaging and quantitative analysis solutions, to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growing Viz Neuro Suite beyond its already market-leading neuro offerings. The collaboration will begin with a focus on multiple sclerosis (MS), integrating quantitative MRI analysis from NeuroQuant MS directly into Viz.ai's care coordination workflow, giving clinicians both the quantitative precision and the coordination infrastructure needed to identify and manage MS patients at scale. “Viz.ai's co
SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO9.7.2026 14:51:00 CEST | Press release
The Supervisory Board of SCP Standard Capital Partners AG (WKN: A12UPJ | ISIN: DE000A12UPJ7 | XETRA ticker: CAP) resolved today to appoint Mr. Fabian Becker as Chairman of the Management Board and Chief Executive Officer (CEO), effective as of 9 July 2026. Ms. Stephanie Schettler-Köhler will remain a member of the Management Board and will assume the role of Chief Operating Officer (COO). View source version on businesswire.com: https://www.businesswire.com/news/home/20260709982268/en/
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis9.7.2026 14:45:00 CEST | Press release
Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both intravenous and subcutaneous formulations.Agreement advances Teva’s Pivot to Growth strategy by expanding its biosimilars pipeline through strategic collaborations.Agreement reflects both companies’ commitment to broadening access to biologic medicines. Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA) and Polpharma Biologics International AG today announced a global licensing agreement granting Teva exclusive rights to commercialize both formulations of Polpharma Biologics’ proposed biosimilar to Ocrevus®1 (ocrelizumab), upon regulatory approval. This strategic agreement is expected to combine Polpharma Biologics’ proven biosimilar development expertise with Teva’s commercial footprint and capabilities. This press release features multimedia. View the full release here: https://www.bus
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom